Shiraz E-Medical Journal

Published by: Kowsar
Crossmark

Medication Adherence and its Predictors in Type 2 Diabetic Patients Referring to Urban Primary Health Care Centers in Kerman City, Southeastern Iran

Lila Benrazavy 1 and Ali Khalooei ORCID 1 , *
Authors Information
1 Social Determinants of Health Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran
Article information
  • Shiraz E-Medical Journal: 20 (7); e84746
  • Published Online: May 19, 2019
  • Article Type: Research Article
  • Received: September 29, 2018
  • Revised: December 30, 2018
  • Accepted: January 11, 2019
  • DOI: 10.5812/semj.84746

To Cite: Benrazavy L, Khalooei A. Medication Adherence and its Predictors in Type 2 Diabetic Patients Referring to Urban Primary Health Care Centers in Kerman City, Southeastern Iran, Shiraz E-Med J. Online ahead of Print ; 20(7):e84746. doi: 10.5812/semj.84746.

Abstract
Copyright © 2019, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. World Health Organization. Global report on diabetes. 2016. Available from: http://www.who.int/diabetes/global-report/en/.
  • 2. Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88-98. doi: 10.1038/nrendo.2017.151. [PubMed: 29219149].
  • 3. Noshad S, Afarideh M, Heidari B, Mechanick JI, Esteghamati A. Diabetes care in Iran: Where we stand and where we are headed. Ann Glob Health. 2015;81(6):839-50. doi: 10.1016/j.aogh.2015.10.003. [PubMed: 27108151].
  • 4. Inamdar SZ, Kulkarni RV, Karajgi SR, Manvi FV, Ganachari MS, Kumar BM. Medication adherence in diabetes mellitus: An overview on pharmacist role. Open J Adv Drug Delivery. 2013;1(3):238-50.
  • 5. Chaudhury A, Duvoor C, Reddy Dendi VS, Kraleti S, Chada A, Ravilla R, et al. Clinical review of antidiabetic drugs: Implications for type 2 diabetes mellitus management. Front Endocrinol (Lausanne). 2017;8:6. doi: 10.3389/fendo.2017.00006. [PubMed: 28167928]. [PubMed Central: PMC5256065].
  • 6. Nash J. Understanding barriers to medication adherence in people with diabetes. J Diabetes Nurs. 2013;17(7):263-7.
  • 7. Lam WY, Fresco P. Medication adherence measures: An overview. Biomed Res Int. 2015;2015:217047. doi: 10.1155/2015/217047. [PubMed: 26539470]. [PubMed Central: PMC4619779].
  • 8. Elsous A, Radwan M, Al-Sharif H, Abu Mustafa A. Medications adherence and associated factors among patients with type 2 diabetes mellitus in the gaza strip, Palestine. Front Endocrinol (Lausanne). 2017;8:100. doi: 10.3389/fendo.2017.00100. [PubMed: 28649231]. [PubMed Central: PMC5465265].
  • 9. Park KA, Kim JG, Kim BW, Kam S, Kim KY, Ha SW, et al. Factors that affect medication adherence in elderly patients with diabetes mellitus. Korean Diabetes J. 2010;34(1):55-65. doi: 10.4093/kdj.2010.34.1.55. [PubMed: 20532021]. [PubMed Central: PMC2879904].
  • 10. Sharma T, Kalra J, Dhasmana DC, Basera H. Poor adherence to treatment: A major challenge in diabetes. J Indian Acad Clin Med. 2014;15(1):26-9.
  • 11. Rwegerera GM, Moshomo T, Gaenamong M, Oyewo TA, Gollakota S, Mhimbira FA, et al. Antidiabetic medication adherence and associated factors among patients in Botswana; implications for the future. Alexandria J Med. 2018;54(2):103-9. doi: 10.1016/j.ajme.2017.01.005.
  • 12. Lee CS, Tan JHM, Sankari U, Koh YLE, Tan NC. Assessing oral medication adherence among patients with type 2 diabetes mellitus treated with polytherapy in a developed Asian community: A cross-sectional study. BMJ Open. 2017;7(9). e016317. doi: 10.1136/bmjopen-2017-016317. [PubMed: 28912194]. [PubMed Central: PMC5640112].
  • 13. Mashrouteh M, Khanjani N. Evaluation of oral medication adherence and its related factors in type II diabetic patients in Iran: A systematic review. Int J Diabet Res. 2017;6(1):24-33. doi: 10.5923/j.diabetes.20170601.04.
  • 14. Plos One Staff . Correction: Validity and reliability of a self-reported measure of antihypertensive medication adherence in Uganda. PLoS One. 2017;12(10). e0187620. doi: 10.1371/journal.pone.0187620. [PubMed: 29088305]. [PubMed Central: PMC5663509].
  • 15. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10(5):348-54. [PubMed: 18453793]. [PubMed Central: PMC2562622].
  • 16. Moharamzad Y, Saadat H, Nakhjavan Shahraki B, Rai A, Saadat Z, Aerab-Sheibani H, et al. Validation of the Persian version of the 8-item morisky medication adherence scale (MMAS-8) in Iranian hypertensive patients. Glob J Health Sci. 2015;7(4):173-83. doi: 10.5539/gjhs.v7n4p173. [PubMed: 25946926]. [PubMed Central: PMC4802120].
  • 17. Dehghan M, Nayeri N, Karimzadeh P, Iranmanesh S. Psychometric properties of the persian version of the morisky medication adherence scale-8. Brit J Med Res. 2015;9(9):1-10. doi: 10.9734/bjmmr/2015/17345.
  • 18. Jimmy B, Jose J. Patient medication adherence: Measures in daily practice. Oman Med J. 2011;26(3):155-9. doi: 10.5001/omj.2011.38. [PubMed: 22043406]. [PubMed Central: PMC3191684].
  • 19. Lin LK, Sun Y, Heng BH, Chew DEK, Chong PN. Medication adherence and glycemic control among newly diagnosed diabetes patients. BMJ Open Diabetes Res Care. 2017;5(1). e000429. doi: 10.1136/bmjdrc-2017-000429. [PubMed: 28878942]. [PubMed Central: PMC5574459].
  • 20. Kirkman MS, Rowan-Martin MT, Levin R, Fonseca VA, Schmittdiel JA, Herman WH, et al. Determinants of adherence to diabetes medications: Findings from a large pharmacy claims database. Diabetes Care. 2015;38(4):604-9. doi: 10.2337/dc14-2098. [PubMed: 25573883]. [PubMed Central: PMC4370331].
  • 21. Serap T, Bayram Ş. Factors influencing adherence to diabetes medication in Turkey. Sch J Appl Med Sci. 2015;3(2A):602-7.
  • 22. Goh BQ, Tay AHP, Khoo RSY, Goh BK, Lo PFL, Lim CJF. Effectiveness of medication review in improving medication knowledge and adherence in primary care patients. Proc Singapore Healthcare. 2014;23(2):134-41. doi: 10.1177/201010581402300207.
  • 23. Bazargan M, Smith J, Yazdanshenas H, Movassaghi M, Martins D, Orum G. Non-adherence to medication regimens among older African-American adults. BMC Geriatr. 2017;17(1):163. doi: 10.1186/s12877-017-0558-5. [PubMed: 28743244]. [PubMed Central: PMC5526276].
  • 24. Katz LL, Anderson BJ, McKay SV, Izquierdo R, Casey TL, Higgins LA, et al. Correlates of medication adherence in the TODAY cohort of youth with type 2 diabetes. Diabetes Care. 2016;39(11):1956-62. doi: 10.2337/dc15-2296. [PubMed: 27352955]. [PubMed Central: PMC5079608].
  • 25. El-Khawaga G, Abdel-Wahab F. Knowledge, attitudes, practice and compliance of diabetic patients in Dakahlia, Egypt. Europ J Res Med Sci. 2015;3(1).
  • 26. Polonsky WH, Henry RR. Poor medication adherence in type 2 diabetes: Recognizing the scope of the problem and its key contributors. Patient Prefer Adherence. 2016;10:1299-307. doi: 10.2147/PPA.S106821. [PubMed: 27524885]. [PubMed Central: PMC4966497].
  • 27. Ahmad NS, Ramli A, Islahudin F, Paraidathathu T. Medication adherence in patients with type 2 diabetes mellitus treated at primary health clinics in Malaysia. Patient Prefer Adherence. 2013;7:525-30. doi: 10.2147/PPA.S44698. [PubMed: 23814461]. [PubMed Central: PMC3693921].
  • 28. Tiv M, Viel JF, Mauny F, Eschwege E, Weill A, Fournier C, et al. Medication adherence in type 2 diabetes: The ENTRED study 2007, a French population-based study. PLoS One. 2012;7(3). e32412. doi: 10.1371/journal.pone.0032412. [PubMed: 22403654]. [PubMed Central: PMC3293796].
  • 29. Farsaei S, Sabzghabaee AM, Amini M, Zargarzadeh AH. Adherence to statin therapy in patients with type 2 diabetes: An important dilemma. J Res Med Sci. 2015;20(2):109-14. [PubMed: 25983760]. [PubMed Central: PMC4400702].
  • 30. Jimmy B, Jose J, Al-Hinai ZA, Wadair IK, Al-Amri GH. Adherence to medications among type 2 diabetes mellitus patients in three districts of Al Dakhliyah Governorate, Oman: A cross-sectional pilot study. Sultan Qaboos Univ Med J. 2014;14(2):e231-5. [PubMed: 24790747]. [PubMed Central: PMC3997541].
  • 31. Sweileh WM, Zyoud SH, Abu Nab'a RJ, Deleq MI, Enaia MI, Nassar SM, et al. Influence of patients' disease knowledge and beliefs about medicines on medication adherence: Findings from a cross-sectional survey among patients with type 2 diabetes mellitus in Palestine. BMC Public Health. 2014;14:94. doi: 10.1186/1471-2458-14-94. [PubMed: 24479638]. [PubMed Central: PMC3909379].
  • 32. Sarbacker GB, Urteaga EM. Adherence to insulin therapy. Diabetes Spectr. 2016;29(3):166-70. doi: 10.2337/diaspect.29.3.166. [PubMed: 27574371]. [PubMed Central: PMC5001221].
  • 33. Donnelly LA, Morris AD, Evans JM, Darts Memo collaboration . Adherence to insulin and its association with glycaemic control in patients with type 2 diabetes. QJM. 2007;100(6):345-50. doi: 10.1093/qjmed/hcm031. [PubMed: 17504861].
  • 34. Mukherjee S. Compliance to anti-diabetic drugs: Observations from the diabetic clinic of a medical college in Kolkata, India. J Clin Diagn Res. 2013. doi: 10.7860/jcdr/2013/5352.2876.
  • 35. Polonsky WH. Poor medication adherence in diabetes: What's the problem? J Diabetes. 2015;7(6):777-8. doi: 10.1111/1753-0407.12306. [PubMed: 25929829].
  • 36. Ivanov NN. Patient-physician communication and diabetes self-care. J Clin Outcomes Manag. 2016;23(11):509-18.
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments